Article
Author(s):
Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending July 23, 2022.
Patients with rheumatoid arthritis (RA) have a higher risk of cancer, but does treatment of rheumatoid arthritis affect that risk? Test your knowledge with this quiz.
Treatment with apremilast was associated with extended time to biologic initiation when compared with treatment with methotrexate.
Previous assessments of the prevalence of lupus were conducted in short periods of time, therefore limiting the insight into long-term trends and potential explanations for the observed patterns.
As treatment options expand in SLE with an increasing number of targeted therapeutics, we can be optimistic about the potential to improve disease outcomes.
“Understanding the impact of COVID-19 infection on children and young people with RMDs is important to inform national protection, education (such as school attendance), and vaccination guidance."